Crimean-Congo hemorrhagic fever

Revision as of 07:25, 31 August 2015 by Rossdonaldson1 (talk | contribs)

Background

  • A tick-borne virus (Nairovirus) in the Bunyavirus family
  • Regions: Eastern Europe, Mediterranean, NW China, central Asia, southern Europe, Africa, Middle East, Indian subcontinent
  • Ixodid ticks are reservoir and vector; direct transmission via body fluids
  • First described in the Crimea and later in the Congo

Clinical Features

History:

  • Exposure risk factors: animal herders, livestock workers, slaughterhouse workers, and healthcare workers in endemic areas
  • Incubation period usually lasts less than one week from exposure
  • Sudden onset of: headache, high fever, back/joint/stomach pain, vomiting, photophobia
  • Mood swing and confusion develop after initial symptoms, followed by sleepiness and depression.
  • Abdominal pain migrates to RUQ

Physical Exam:

  • Conjunctivitis, facial flushing, palatal erythema and petechiae, lymphadenopathy,
  • Jaundice and changes in mood and sensory perception
  • Signs of coagulopathy (starting around day 4)
  • Palpable hepatomegaly

Clinical Course: Estimated 9-50% mortality

Differential Diagnosis

Fever in traveler

Diagnosis

Labs:

  • Antigen-capture ELISA
  • RT-PCR
  • Virus isolation
  • Antibody ELISA

Imaging: None

Management

  • Supportive
  • IV/PO Ribavirin

Disposition

Admission

See Also

Viral hemorrhagic fevers

References

  • Crimean-Congo Hemorrhagic Fever (CCHF). www.cdc.gov. [1]. Updated [5/9/15].
  • Crimean-Congo Hemorrhagic Fever (CCHF). World Health Organization Fact Sheet. [2].
  • Rosen's Emergency Medicine. 8e. 2013.